Atlas Trials

Wild-Type Reovirus in Combination With Carfilzomib and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

Clinical trial NCT02101944 · COMPLETED

Trial details

NCT number
NCT02101944
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
AnemiaRecurrent Multiple MyelomaRefractory Multiple Myeloma
Start date
2014-12-09
Primary completion
2021-05-05
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.